BAFNAPH Share Price Target 2028

CAGR-based price projection for Bafna Pharmaceuticals Limited (BAFNAPH) targeting 2028, derived from official NSE exchange closing prices.

Bear Case (9.6% CAGR)
Rs 210
2028 Target
Base Case (23.9% CAGR)
Rs 268
2028 Target
Bull Case (69.5% CAGR)
Rs 502
2028 Target

Current Market Snapshot

CMP: Rs 174.58
52W High: Rs 193.97
52W Low: Rs 129.90
1Y CAGR: 53.5%
3Y CAGR: 23.9%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 191 Rs 216 Rs 296
2028 Rs 210 Rs 268 Rs 502

Other BAFNAPH Price Targets

2025 2026 2027 2030 2035 2040 2050

Frequently Asked Questions

What is the BAFNAPH share price target for 2028?

Based on historical growth analysis, the BAFNAPH share price target for 2028 ranges from Rs 210 (conservative) to Rs 268 (base case) to Rs 502 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of BAFNAPH?

The current market price of BAFNAPH (Bafna Pharmaceuticals Limited) is Rs 174.58. The 52-week high is Rs 193.97 and 52-week low is Rs 129.90.

Is BAFNAPH a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for BAFNAPH price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 9.6% CAGR), Base (23.9% CAGR), and Bull (optimistic at 69.5% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.